港股异动 | 荣昌生物(09995.HK)尾盘涨近6% 旗下RC148获FDA批准在美国开展II期临床试验

智通财经
Aug 08, 2025
【港股异动 | 荣昌生物(09995.HK)尾盘涨近6% 旗下RC148获FDA批准在美国开展II期临床试验】智通财经APP获悉,荣昌生物(09995.HK)尾盘涨近6%,截至发稿,涨5.79%,报64港元,成交额4.79亿港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10